Performance of fluid balance as a marker of acute kidney injury in children after open heart surgery by Krastiņš, Jēkabs et al.
INTRODUCTION
Acute kidney injury (AKI) is a serious complication in the
perioperative period and is consistently associated with in-
creased morbidity and case fatality rate. This has been best
studied in the cardiac surgery setting where it has been
shown that up to 11.5–86% of patients exposed to cardio-
pulmonary bypass (CPB) will develop AKI, with 2–18.9%
requiring renal replacement therapy (RRT). Depending on
the criteria used to define AKI and the postoperative period
studied, mortality ranges from 1% to 30%, although this is
consistently higher, approaching 80%, if RRT is required.
AKI may contribute to chronic kidney disease and negative
long-term health outcomes. There is no clear understanding
of the pathogenesis of CPB associated AKI and no effective
treatment or prevention has yet been established for this
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Acute kidney injury (AKI) is a serious complication in the perioperative period and is consistently
associated with increased morbidity and case fatality rate. This has been best studied in the car-
diac surgery setting where it has been shown that up to 11.5–86.0% of patients exposed to
cardiopulmonary bypass (CPB) will develop AKI, with 2.0–18.9% requiring renal replacement
therapy (RRT). A prospective uncontrolled cohort study was conducted between 2011 and 2015,
in which 93 children with various congenital heart lesions undergoing CPB were enrolled. Serum
creatinine (SCr) level was determined by Jaffé’s method (Cobas 6000 analyser, Roche). Postop-
erative fluid balance was estimated as the difference between fluid intake and output. Data for
further processing were retrieved from anaesthesia and intensive care data management system
flowsheets (IntelliView, Philips). AKI developed in 42 patients (45.6%) by meeting at least KDIGO
(Kidney Disease: Improving Global Outcomes) stage I criteria (with SCr rise by more than 50%
from the baseline). Thirty eight patients complied with the 1st stage of AKI, three with 2nd stage
and two with 3rd stage, according the KDIGO classification and staging system. One patient hav-
ing severity stage II and two patients having severity stage III of AKI required initiation of RRT us-
ing peritoneal dialysis. Two patients from the RRT group survived, one died. The median
intraoperative urine output was 2.32 ml/kg/h, (range from 0.42–5.87 ml/kg/h). Median CPB time
was 163 min., median aortic cross-clamping time was 97.9 min., cooling during CPB to 29.5 °C.
The diagnosis of AKI using SCr was delayed by 48 hours after CPB. Median fluid balance (FB) on
the first postoperative day in non-AKI patients was 13.58 ml/kg (IQR 0–37.02) vs 49.38 ml/kg
(IQR 13.20–69.32) in AKI patients, p < 0.001. AKI is a frequent complication after open heart sur-
gery in children with congenital heart lesions. From 93 patients included in the study, 42 (45.2%)
met at least KDIGO Stage I criteria for AKI. FB is a sensitive marker of kidney dysfunction. Me-
dian FB in the 1st postoperative day significantly differed between AKI patients: 49.38 ml/kg
(13.20–69.32) versus 13.58 ml/kg in patients with intact kidney function (AUC = 0.84; p = 0.001).
Thus it can be used as a marker of AKI.
Key words: acute kidney injury, fluid balance, paediatric open-heart surgery.
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syndrome. Fluid overload (FO), which often accompanies
significant AKI, was first recognised in a retrospective
study of paediatric bone marrow transplant patients (Lane et
al., 1994). Studies of adult critically ill patients have shown
that positive FB above 10% is associated with higher
long-term mortality and higher occurrence of AKI, thus in-
dicating this threshold as a potential indicator of adverse
outcome (Van Biesen et al. 2005). The study of Hassinger
et al. showed that patients with early positive FB, more than
5% by the end of POD 1, were more likely to develop AKI
(43.3% vs 33.8%, p = 0.023). The authors also observed
that positive FB was associated with a prolonged lengths of
hospital stay (3.5 more days in the hospital), two more days
on inotropes, and increased prevalence of prolonged me-
chanical ventilation (Hassinger et al., 2014).
MATERIALS AND METHODS
Children undergoing elective CPB for surgical correction or
palliation of congenital heart lesions between January 2011
and June 2015 were prospectively enrolled. Exclusion crite-
ria included preexisting renal dysfunction. Renal dysfunc-
tion was defined as a SCr level that was greater than the
90th percentile for the child’s age and gender. Patients with
a history of potential nephrotoxin use during the preopera-
tive day were excluded because of potential confounding ef-
fects. Ethical approval was obtained from the Ethics Com-
mittee of the Children’s Clinical University Hospital.
Creatinine concentrations were measured in the hospital’s
clinical chemical laboratory using Jaffes method on a Cobas
8000 analyser. The primary outcome variable was the de-
velopment of AKI. AKI was defined according to the
KDIGO classification and staging system based on urine
output and SCr level: Stage I was SCr 1.5–1.9 times base-
line  26.5 µmol/L increase or UO < 0.5 ml/kg/h for 6–12
hours, stage II was SCr 2–2.9 times baseline and UO < 0.5
ml/kg/h for  12 hours, stage III was SCr 3 times baseline
or  354 µmol/L and/or UO < 0.3 ml/kg/h for  24 hours
OR anuria for  12 hours (Kellum et al., 2012).
Intraoperative fluid intake was assessed by total of intra-
venous fluid volume, cardioplegia volume, and pump vol-
ume (total volume added during cardiopulmonary bypass
plus reservoir volume at the start of cardiopulmonary by-
pass minus reservoir volume at the termination of cardio-
pulmonary bypass). Intraoperative fluid output was the total
of urine produced on cardiopulmonary bypass, chest tube
drainage before the patient left the operating room, and esti-
mated blood loss. Intraoperative net fluid balance was the
difference between fluid intake and output. Data for further
processing were retrieved from anaesthesia and intensive
care data management IntelliView Clinical Information
Portfolio (Philips) system flowsheets (Fig. 1). Similarly,
fluid balance was calculated after the completion of surgical
repair. Patient data were collected from day of admission to
Intensive care (denoted as POD-1).
Sample collection and processing. Creatinine concentra-
tions were measured in the hospital’s clinical chemical lab-
oratory by Jaffes method on a Cobas 8000 analyser. All
samples were obtained at the following time points: (1) pre-
operative; (2) 24 hours and (3) 48 hours after the surgical
repair. The primary outcome variable was the development
of AKI. AKI was defined according to the KDIGO classifi-
cation and staging system based on urine output and SCr
level: Stage I was SCr 1.5–1.9 times baseline  26.5 µmol/L
increase or UO < 0.5 ml/kg/h for 6–12 hours, stage II was
SCr 2–2.9 times baseline and UO < 0.5 ml/kg/h for  12
hours, stage III was SCr 3 times baseline or  354 µmol/l
and/or UO 0.3 ml/kg/h for  24 hours OR anuria for  12
hours (Kellum et al., 2012). Recorded variables included
age, gender, CPB time, lowest temperature during CPB and
urine output, doses of diuretics, inotropes and vasopressors,
and postoperative fluid balance. Outcome variables in-
cluded percent change in serum creatinine, days in AKI, di-
alysis requirement, duration of MV, lengths of stay in ICU
and hospital LOS.
Anaesthesia management. Induction to anaesthesia was
provided using inhalation of Sevoflurane by face mask or in-
travenously by Propofol or Midazolam in combination with
Ketamine. Anaesthesia was maintained at (0.8–1.0 minimal
alveolar concentration) of sevoflurane and fentanyl (3–5 µg
kg/h) using a Primus anaesthesia machine (Drãger Medical,
Lübeck, Germany). Muscle relaxation was achieved with
pipecuronium (0.6 mg/kg). During CPB, isoflurane was ap-
plied via the CPB circuit. All patients were ventilated in a vol-
ume-controlled mode; with a tidal volume of 6 ml/kg and re-
spiratory rate adjusted to achieve normocapnia. The
heart-lung machine SORIN S 5 (LivaNova, United King-
dom) with a membrane oxygenator Affinity Pixie ®
Oxygenatior (Medrtronics, USA) was used for neonates, in-
fants and small children requiring cardiopulmonary bypass at
flow rates up to 2.0 L/min. For older patients Terumo,
Medtronic C oxygenator with CPB circuit was used. Surgical
procedures were performed with CPB in moderate hypother-
mia. Cardioplegic arrest was achieved by cold blood
cardioplegia and repeated every 20 minutes. Nonpulsatile
perfusion was performed during CPB. Pump flow, oxygen
flow, and MAP were adjusted to maintain ScvO2 levels
within the preoperative range and at least higher than 50% ab-
solute. In patients monitored with a pulmonary artery catheter
(PAC), haemodynamic therapy was titrated to achieve car-
Fig. 1. Age distribution
of patients.
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diac index > 2.2 L/min/m2 and mixed venous oxygen satura-
tion (Sv O2) greater than 65%.
Fluid therapy was performed with balanced crystalloid
(Lactated Ringers solution, Sterofundin VG, BBraun;
Melsungen, Germany). The pump prime consisted of vari-
ous amounts of Ringer lactate and whole blood, depending
on estimated blood volume, haematocrit, and total priming
volume used. Hypothermic myocardial protection was pro-
vided by core cooling at flow rates of 150 to 200 ml/kg/
min. (2.0 to 3.0 kg) or 100 to 150 ml/kg/min. (3.0 to 5.0 kg)
to rectal and esophageal temperatures of  30°C, followed
by aortic cross clamping. Once optimal hypothermic tem-
peratures were reached, continuous low-flow cardiopulmon-
ary bypass was instituted during completion of intracardiac
stage. Core rewarming was instituted during completion of
the intracardial stage. Mean perfusion pressures were main-
tained between 30 mm Hg and 70 mm Hg during
rewarming. All patients were weaned from cardio-
pulmonary bypass after the rectal temperature reached
35 °C. Lactated Ringers, fresh whole blood, blood products,
and increased inotropic support were given as necessary to
maintain normal filling pressures and a systolic perfusion
pressure of at least 60 mm Hg.
Postoperative management. Analgesia and sedation were
provided by a continuous fentanyl or morphine infusion,
typically 2–4 µg kg-1·h-1 and Midazolam or Dexmedeto-
midine. Routine continuous postoperative monitoring in-
cluded the surface ECG, transcutaneous pulse oximetry,
pulmonary arterial and right and left atrial pressures
(through transthoracic catheters), and systemic arterial pres-
sure. Inotropic, chronotropic, and afterload reducing agents
were used as clinically indicated. Vasoactive medications
were typically started in the operating room at the discretion
of the attending cardiac surgeon and anaesthesiologist based
on individual patient characteristics, including, residual le-
sions, transesophageal echocardiographic findings, and
physiological status. On arrival to the ICU, medications are
adjusted by the bedside nurse under the direction of the ICU
team. Patients with hypotension typically receive norepine-
phrine and epinephrine initially, volume infusions (plasma
or 5% albumin) were given to maintain adequate filling
pressures with systolic perfusion pressures of at least 50
mm Hg. Diuretics (usually furosemide 1 to 2 mg/kg per
dose, two to four times daily) were prescribed at the attend-
ing physician’s discretion if a targeted fluid balance or urine
output of > 0.5 ml/kg/hour could not be achieved. Some pa-
tients received continuous infusion of Furosemide and
Aminophilline.
During the study continuous fentanyl or morphine infusions
were discontinued on the first postoperative morning in the
haemodynamically stable patient or continued for longer pe-
riods as dictated by the clinical status of the patient. Me-
chanic ventilation was provided with a Viasys Avea ventila-
tor (Cardinal Health, USA) at the mode suitable for specific
cardiac lesion. The rate of weaning of mechanical ventila-
tion was determined by the patient’s fluid balance and gas
exchange as indicated by arterial blood sampling, pattern of
breathing, and daily radiographic findings.
The initial mode of ventilation was pressure-regulated vol-
ume control in all patients. Once the patient was breathing
spontaneously and ready for weaning, the ventilator mode
was switched to pressure-controlled, synchronised, intermit-
tent, mandatory ventilation.
The criteria for extubation was protocolised, as follows: sta-
ble haemodynamic profile, normal cardiac rhythm, adequate
oxygenation on fraction of inspired oxygen < 0.4, mainte-
nance of a pH > 7.35, and PacCO2 < 45 mm Hg on continu-
ous positive airway pressure < 6 cm H2O with pressure sup-
port < 8 cm H2O for at least 1 h, the level of consciousness
consistent with adequate airway protective reflexes, absence
of accessory respiratory muscle recruitment, and approval
by the attending intensivists. Corticosteroids were routinely
administrated 4 to 6 h before extubation. All patients were
monitored with invasive arterial and central blood pressure
monitoring. In patients undergoing complex cardiac sur-
gery, a left atrial or pulmonary artery catheter was inserted
during surgical repair. Transesophageal echocardiography
was performed in all valve surgery cases. Cerebral oxygen
saturation (ScO2) was determined in all patients with an IN-
VOS 5100 monitor (Somanetics, Troy, USA). All patients
received routine standard care during the study period,
which included the use of dextrose-containing crystalloid
solutions (Sterofundin HEG, Sterofundin BG, Sterofundin
VG (BBraun, Melsungen, 50–80 ml/kg/day) during the first
24–48 hours postoperatively, followed by the initiation of
enteral tube feeding.
Statistical methods. Unless indicated otherwise, continu-
ous data are expressed as median values with interquartile
range (IQR) and discrete data as numbers with percentages
(%). Patients were grouped according to whether they
lacked AKI or had AKI within 48 hours following CPB.
Clinical characteristics and biomarker levels were compared
between AKI and non-AKI patients using the Student’s t
test for normally distributed continuous variables. The
Mann-Whitney U test was performed for non-normally dis-
tributed continuous variables and Pearson’s 2 or Fisher’s
exact test (as appropriate) was performed on all categorical
variables. Statistical significance was defined as a probabil-
ity value less than 0.05. Univariate logistic analysis was
performed to examine the relationship between multiple
clinical variables as well as the presence of AKI and clinical
outcomes (ICU length of stay, hospital length of stay, dura-
tion of mechanical ventilation, and in-hospital mortality).
Variables with a probability value less than 0.1 were then
cast into a multivariate logistic regression analysis. Odds ra-
tio, CI, and probability values were calculated. All
univariate and multivariate logistic regression analyses were
conducted for the entire cohort. Receiver operating charac-
teristics (ROC) curves were generated for the occurrence of
AKI within 48 hours following cardiopulmonary bypass us-
ing FB at POD-1. The areas under the curve (AUC), with
95% confidence intervals (95% CI), were calculated. Also,
the optimal cut-off value was calculated with corresponding
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sensitivity and specificity. Using those cut-off values, sensi-
tivity and specificity of FB for predicting AKI were calcu-
lated for patients who developed AKI. Two-sided p = 0.05
was considered the limit of significance in all analyses.
Data were analysed using IBM SPSS statistics version 21
(Statistical Package for the Social Sciences, Chicago, IL).
RESULTS
Median age of patients was ten months, and body weight
was 7.6 kg (Table 1). The majority from 93 included pa-
tients 54 (58.00%) were less than 12 months old, 6 patients
(6.45%) were less than 1 months old, 20 (21.51%) patients
were between 1 and 6 months of age; and 28 (30.11%) pa-
tients had age of 7 to 12 months were. Age group of 1 to 3
years represents 23 (24.73%) children. 6.45% were patients
between 3 to 7 years, and 10.75% were older than 7 years,
(Fig. 2, Table 2). Types of congenital heart lesions are sum-
marised in Table 3.
Postoperative AKI occurred in 42 (45.16%) of 93 children.
Thirty-seven of them reached severity stage I according the
KDIGO classification and stating system, three reached
stage II and two reached stage III, based on SCr and (or)
urine output criteria (Fig. 3). Fig. 4 shows changes in %
from the baseline SCr concentration to maximum during 48
hours. It shows number of patients for each AKI severity
stage.
Postoperative fluid balance (FB POD-1) was 13.58 ml/kg
(median) in the non-AKI group versus 27.20 ml/kg in the
AKI group, p = 0.025 (Fig. 5, Table 4). In addition, FB was
calculated separately according the severity stage of AKI.
T a b l e 1
DEMOGRAPHIC DATA
Variable Median IQR (Q1–Q3) Range
Age, months 10.0 6.0–17 0.2–180.0
Body weight (kg) 7.6 5.6–10 2.6–60.0
M/F ratio:
35/58
T a b l e 2
AGE STRUCTURE
Age group Number of patients (%)
Less than 1 month 6 6.45
1 < 6 months 20 21.51
7 < 12 months 28 30.11
1 < 3 years 23 24.73
3 < 7 years 6 6.45
7 years and older 10 10.75
Total: 93 100.00
Fig. 2. Severity of acute kid-
ney injury.
T a b l e 3
TYPES OF SURGICAL INTERVENTION
Surgical intervention Number of
patients
%
AVSD (atrioventricular septal defect) repair 20 21.51
DORV (double outlet right ventricle) 3 3.23
Pulmonary stenosis repair 5 5.38
Tricuspid regurgitation repair 2 2.15
Unifocalization procedure 2 2.15
Aortic stenosis repair 3 3.23
VSD (ventricular septal defect) repair 37 39.78
Mitral valve plastics 2 2.15
TAPVD (total anomalous pulmonary vein drainage) 4 4.30
TGA (transposition of great arteries) 6 6.45
TOF (tetralogy of Fallot) 9 9.68
Total: 93 100.00
Fig. 4. Postoperative fluid balance (screenshot from the ICIP (Philips) pa-
tient data management system).
Fig. 3. SCr (serum creatinine) histogram.
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Fluid balance in patients reaching 1st stage of AKI severity
increased from 13.58 ml/kg (median) to 26.27 ml/kg, 2nd
stage to 36.29 ml/kg and 3rd stage to 90.09 ml/kg, ANOVA
test p = 0.002 (Fig. 6). To evaluate postoperative fluid bal-
ance as a marker for AKI, ROC analysis was performed
(Fig. 7). AUC was 0.842 (CI 95% 0.838–0.926), sensitivity
of 80%, specificity of 71% and cut-off value of 25 ml/kg.
DISCUSSION
Studies of paediatric patients requiring RRT showed corre-
lation of the degree of positive FB with poor outcome and
mortality, hinting at a dynamic positive FB value for pre-
dicting adverse outcomes, with the 10% cut-off value prov-
ing to be clinically significant (Horiguchi et al., 2014). In-
fants 72 hours after cardiac surgery with a positive fluid
balance had 10 times higher odds of prolonged mechanical
ventilation than infants without a positive fluid balance (Shi
et al., 2008). Patients with  20% fluid overload had an
8.5-fold greater adjusted odds ratio of death than those with
less than 20% fluid overload (Sutherland et al., 2010). A re-
cent study by Hassinger et al. (2014) also demonstrated that
increasing positive FB, as measured by daily fluid balance,
is associated with worse outcome following congenital heart
surgery in infants. In the study of Lex et al. (2016), where
postoperative FB was analysed in 1520 paediatric patients
after open heart surgery, there was a positive FB between
5% and 10% in 120 patients (7.8%), and in 33 patients
(2.1%) FB was above 10%. Multivariable analysis showed
that higher fluid overload on the day of the surgery was in-
dependently associated with mortality (adjusted odds ratio,
1.14; 95% CI, 1.008–1.303; p = 0.041) and low cardiac out-
put syndrome (adjusted odds ratio, 1.21; 95% CI,
1.12–1.30; p = 0.001). Higher maximum SCys C levels (ad-
justed odds ratio, 1.01; 95% CI, 1.003–1.021; p = 0.009),
maximum vasoactive-inotropic scores (adjusted odds ratio,
1.01; 95% CI, 1.005–1.029; p = 0.042), and higher blood
loss on the day of the surgery (adjusted odds ratio, 1.01;
95% CI, 1.004–1.025; p = 0.015) were associated with a
T a b l e 4
CLINICAL OUTCOME CHARACTERISTICS BY AKI STATUS
Variable/category Non-AKI AKI p value





FB POD-1  50 ml/kg, n (%) 18/51 (35.29%) 25/42 (59.52%) 0.046
#
#Fisher’s exact test, *Mann–Whitney U test
Fig. 5. Fluid balance (FB) at POD-1 (patient data collected from day of ad-
mission to intensive care) in acute kidney injury (AKI) and non-AKI pa-
tients. Box and whisker plot showing FB (ml/kg) in AKI (filled box) and
non-AKI (empty box) patients.
Fig. 6. Postoperative fluid balance (FB) and severity of acute kidney injury
(AKI). Box and whisker plot showing FB POD-1 in non-AKI patients
(empty box) and patients having Ist, 2nd and 3rd stage of AKI (filled boxes).
Fig. 7. Receiver operating characteristics curve of fluid balance POD-1 in
acute kidney injury (AKI) and non-AKI patients.
T a b l e 5
POSTOPERATIVE FLUID BALANCE (ML/KG) AT POD-1 AND SEVERITY OF AKI
Variable/Severity Non-AKI AKI Ist stage AKI IInd stage AKI IIIrd stage
Median 13.58 26.27 36.29 90.19
Interquartile range (Q1-Q3) 0–37.02 0–39.63 5.60–58.56 70.97–130.61
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higher risk of fluid overload that was greater than 5% (Lex
et al., 2016).
The etiology of positive FB in this patient population is
multifactorial. Cardiopulmonary bypass results in both
haemodilution and increased capillary permeability, both of
which promote extravasation of fluid into the extracellular
fluid compartment (Zhang et al., 2004). Fluid resuscitation
and blood product administration in the immediate postop-
erative period further contributes to third spacing. As body
wall oedema increases, intra-abdominal pressure rises and
renal perfusion pressure is decreased (Wauters et al., 2009).
When combined with postoperative myocardial dysfunc-
tion, there is also a stimulus to retain fluid via the renin-an-
giotensin-aldosterone system (Sorof et al., 1999). Given the
acute nature of CPB mediated kidney injury and the obser-
vation that most infants have normal renal function prior to
surgery, these patients may be ideal candidates for aggres-
sive postoperative goal-directed protocols aimed at minimi-
sation of positive FB. Peritoneal dialysis has been shown to
be a safe and effective method of fluid removal in post-
cardiotomy infants (Pedersen et al. 2008), and early initia-
tion of this therapy can improve haemodynamics and ICU
outcomes (Sorof et al., 1999).
By examining fluid balance early after cardiac surgery, the
current study adds to the growing body of evidence that
positive fluid balance is independently associated with kid-
ney dysfunction. FB POD-1  50 ml/kg, in the non-AKI
group was 35.29% versus 59.52% in AKI group, p = 0.046
(Table 4). Median postoperative fluid balance in the
non-AKI group was 13.58 ml/kg versus 27.20 ml/kg in the
AKI group, p = 0.025 (Table 4, Fig. 5), OR of FB  50
ml/kg in AKI vs. non-AKI was 2.58 (CI 95% 0.94–7.07),
p = 0.026. After performing ROC analysis, AUC of FB
POD-1 was 0.842 with sensitivity of 80%, specificity of
71% (CI 95% 0.838–0.926) and cut-off value was 25 ml/kg,
p = 0.001 (Fig. 7). Similar results were published in the
study of Hassinger et al. (2014). They found postoperative
positive fluid balance > 50 ml/kg in 31% of patients, which
is less than in this study. The reported AUC was 0.963;
95% CI, 0.916–1.000; p = 0.002 (Hassinger et al., 2014).
CONCLUSIONS
Fluid balance is a suitable marker for the prediction of post-
operative AKI. 35.29% patients had FB POD-1  50 ml/kg
in the non-AKI group had versus 59.52% in the AKI group,
p = 0.046. Median postoperative fluid balance in the
non-AKI group was 13.58 ml/kg versus 27.20 ml/kg in the
AKI group, p = 0.025, OR of FB  50 ml/kg in AKI versus
non-AKI was 2.58 (CI 95% 0.94–7.07), p = 0.06. After per-
forming ROC analysis, AUC of FB POD-1 was 0.842 with
sensitivity of 80%, specificity of 71% (CI 95% 0.838–
0.926) and the cut-off value was 25 ml/kg, p = 0.001. The
role of fluid balance in the postoperative management is un-
derestimated and daily FB monitoring now becomes essen-
tial.
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ÐÍIDRUMA BALANSA KÂ NIERU BOJÂJUMA MARÍIERA VEIKTSPÇJA BÇRNIEM PÇC SIRDSKAITES KOREKCIJAS
MÂKSLÎGÂ ASINSRITÇ
Akûts nieru bojâjums (ANB) ir nopietna pçcoperâcijas perioda komplikâcija, kas konsekventi saistîta ar pieaugoðu morbiditâti un
mortalitâti. Tas ir visvairâk pçtîts kardioíirurìijâ, kur pierâdîts, ka lîdz 11,5–86,0% pacientu, kam veic operâcijas MA (mâslîgâ asinsritç),
attîstâs ANB, 2,0–18,9% no tiem nepiecieðama nieru aizstâjçjterapija (NAT). Atkarîbâ no kritçrijiem, ko izmanto, lai definçtu ANB,
mirstîba svârstâs no 1% lîdz 30%, lai gan tas ir konsekventi augstâks, tuvojoties 80%, ja ir nepiecieðams NAT. ANB var veicinât hronisku
nieru slimîbu un negatîvus ilgtermiòa veselîbas rezultâtus. Nav skaidri saprotama ar MA saistîtâ ANB patogenitâte, un ðim sindromam vçl
nav izstrâdâta efektîva ârstçðana vai profilakse. 2011.–2015. gadâ tika veikts prospektîvs nekontrolçts kohortas pçtîjums, kurâ tika iekïauti
93 bçrni ar daþâdâm iedzimtâm sirdskaitçm, kas tika koriìçtas MA. Seruma kreatinîna (SCr) lîmeni noteica ar Jaffé metodi (Cobas 6000
analizators, Roche), ðíidruma balanss (ÐB) tika aprçíinâts kâ starpîba starp kopçjo ievadîto un izdalîto ðíidruma apjomu. Skaitliskie
lielumu tika iegûti, izmantojot IntellyView intensîvâs terapijas klînisko informâcijas sistçmu (Philips). ANB attîstîjâs 42 pacientiem
(45,6%), sasniedzot vismaz KDIGO I smaguma pakâpes kritçrijus (ar SCr pieaugumu vairâk nekâ 50% no izejas koncentrâcijas). 38
pacienti saskaòâ ar KDIGO klasifikâcijas sistçmu sasniedza II, bet divi pacienti sasniedza ANB III smaguma pakâpi. Vienam pacientam ar
II smaguma pakâpi un diviem pacientiem, kuriem bija III smaguma pakâpe, bija nepiecieðama NAT uzsâkðana, izmantojot peritoneâlo
dialîzi. Divi pacienti no NAT grupas izdzîvoja, viens nomira. Mediânâ intraoperatîvas urîna izvade bija 2,32 ml/kg/h (diapazons no
0,42–5,87 ml/kg/h). Vidçjais MA laiks bija 163 min, vidçjais aortas oklûzijas laiks bija 97,9 min, hipotermija lîdz 29,5 °C. ANB diagnoze,
izmantojot SCr, aizkavçjâs 48 stundas pçc MA. Vidçjais pozitîvais ðíidruma balanss (ÐB) pirmajâ pçcoperâcijas dienâ pacientiem ar intaktu
nieru funkciju, bija 13,58 ml/kg (IQR 0,00–37,02) salîdzinâjumâ ar 49,38 ml/kg (IQR 13,20–69,32) pacientiem ar ANB, p fs22 0,001. AKI
ir bieþa komplikâcija pçc sirdskaites korekcijas MA bçrniem. No 93 pçtîjumâ iekïautajiem pacientiem 42 (45,2%) atbilda vismaz KDIGO I
pakâpes ANB kritçrijiem. ÐB ir jutîgs nieru disfunkcijas maríieris. ÐB 1. pçcoperâcijas dienâ ir statistiski nozîmîga atðíirîba starp
pacientiem ar ANB 49,38 ml/kg (IQR 13,20–69,32) salîdzinâjumâ ar 13,58 ml/kg pacientiem ar intaktu nieru funkciju (AUC = 0,84; p =
0,001), un to var izmantot kâ ANB maríieri.
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